NCT05409092 is a NA clinical trial of Astaxanthin in Inflammatory Response, sponsored by Appalachian State University.

Who is sponsoring NCT05409092?

NCT05409092 is sponsored by Appalachian State University.

What drugs are being tested in NCT05409092?

Interventions in NCT05409092: Astaxanthin, Placebo.

What condition does NCT05409092 study?

NCT05409092 studies Inflammatory Response, Metabolic Disturbance, Immune Suppression.

Is NCT05409092 still recruiting?

NCT05409092 is currently completed. Last updated 9 June 2023.

Last reviewed 2023-06-09 · How we verify

NCT05409092

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Astaxanthin, Exercise Inflammation, Skin Health

Completed NA Last updated 9 June 2023

What this trial tests

NA trial testing Astaxanthin in Inflammatory Response in 22 participants. Completed in 30 December 2022.

Timeline

19 January 2022

Primary endpoint
30 July 2022

30 December 2022

Quick facts

Lead sponsor	Appalachian State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	22
Start date	19 January 2022
Primary completion	30 July 2022
Estimated completion	30 December 2022
Sites	1 location across United States

Drugs / interventions tested

Astaxanthin — full drug profile →
Placebo

Conditions studied

Inflammatory Response — all drugs for Inflammatory Response →
Metabolic Disturbance — all drugs for Metabolic Disturbance →
Immune Suppression — all drugs for Immune Suppression →

Sponsor

Appalachian State University

Who can join

Adults 18 to 57, any sex, with Inflammatory Response or Metabolic Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vigorous exercise can stress the body. Consuming special types of diet supplements may help the body recover better from exercise. This includes a bright red supplement called astaxanthin that is found in certain algae and causes the pink-red color in salmon. Astaxanthin is an antioxidant and may protect cells from damage and improve the way the immune system functions. The main purpose of this study is to determine if 4 weeks of consuming astaxanthin improves recovery from 2.25 hours of intensive running on a treadmill. This study will also measure whether or not astaxanthin supplementation improves skin health

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Astaxanthin supplementation counters exercise-induced decreases in immune-related plasma proteins.
Nieman DC, Woo J, Sakaguchi CA, Omar AM, et al · · 2023 · cited 16× · PMID 37025615 · DOI 10.3389/fnut.2023.1143385

Verify or expand the search:

Other trials of Astaxanthin

Trials testing the same drug.

NCT07509970 — Effects of Astaxanthin Supplementation on Soccer Performance Under Fatigue · NA · completed
NCT06460181 — Impact of Astaxanthin on Cognition in Recreationally Active Females · Phase 4 · recruiting
NCT06429059 — ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) · Phase 2 · completed
NCT05138549 — Astaxanthin for Management of Inflammation in Knee Osteoarthritis · Phase 2, PHASE3 · terminated
NCT05376501 — A Study to Evaluate the Effect of Astaxanthin in Healthy Participants · NA · completed

Other recruiting trials for Inflammatory Response

Currently open trials in the same condition.

NCT06450704 — Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders · NA · recruiting
NCT06519487 — Social Experiences and Demographic Factors in the Regulation of Immune Cells · NA · recruiting
NCT06434701 — Severe COVID-19 Infection in Children Presenting to EDs in Israel and England · NA · recruiting
NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
NCT06342024 — Pistachio Consumption on Inflammatory Markers and Lean Body Mass · NA · active not recruiting

Other Appalachian State University trials

Trials by the same sponsor.

NCT07413874 — Telehealth Music Therapy for Adults With Endocrine Disorder and Depression · NA · not yet recruiting
NCT06495190 — Cognition, Flavonoids, Exercise, Gut Microbiome · NA · recruiting
NCT06392360 — Betaine, Exercise Performance, and Gut Permeability · NA · completed
NCT06204666 — Hemp Fiber Ingestion and Gut Permeability After Exercise · NA · completed
NCT05907135 — Beet Supplementation, Exercise, Inflammation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05409092 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Appalachian State University
Last refreshed: 9 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05409092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing